Your browser doesn't support javascript.
loading
Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.
Molenaar, R J; Pleyer, C; Radivoyevitch, T; Sidana, S; Godley, A; Advani, A S; Gerds, A T; Carraway, H E; Kalaycio, M; Nazha, A; Adelstein, D J; Nasr, C; Angelini, D; Maciejewski, J P; Majhail, N; Sekeres, M A; Mukherjee, S.
Afiliación
  • Molenaar RJ; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Pleyer C; Departments of Medical Biology and Medical Oncology, Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Radivoyevitch T; Division of Hematology/Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sidana S; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
  • Godley A; Department of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Advani AS; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Gerds AT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Carraway HE; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Kalaycio M; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Nazha A; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Adelstein DJ; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Nasr C; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Angelini D; Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, OH, USA.
  • Maciejewski JP; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Majhail N; Department of Translational Hematology and Oncologic Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Sekeres MA; Department of Hematology and Medical Oncology, Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Mukherjee S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Leukemia ; 32(4): 952-959, 2018 04.
Article en En | MEDLINE | ID: mdl-29104287
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Leucemia Mielógena Crónica BCR-ABL Positiva / Isótopos de Yodo / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Leucemia Mielógena Crónica BCR-ABL Positiva / Isótopos de Yodo / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos